Clinical trial NCT04732312: Impact of Formal Home Help on Quality of Life for Caregivers of Elderly Patients With Neurocognitive Impairment
Official title: Impact of Formal Home Help on Quality of Life for Caregivers of Elderly Patients With Neurocognitive Impairment: a Prospective Monocenter Study
Study type: OBSERVATIONAL
Overall status: TERMINATED
Conditions: Age-related Cognitive Decline
Keywords: cognitive impairment
caregiver quality of life
caregiver burden
caregiver vulnerability
Lead sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Sponsor class: OTHER
First posted: 2021-02-01
Enrollment: 12
Sex: ALL
Minimum age (years): 60
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Elderly people with neurocognitive disorders benefiting from a home support program (personalized autonomy allowance for seniors program).

Brief summary: The purpose of this prospective monocenter observational study is to assess the impact of the first introduction of formal home help (personalized autonomy allowance for seniors) on the quality of life of home caregivers of elderly patients with neurocognitive impairment.

Detailed description: An aging population is leading to an increase in neurodegenerative disorders that are responsible for loss of autonomy. In order to keep patients with neurocognitive impairment at home, the availability of home caregivers is essential. The neurocognitive deterioration of elderly patients is a significant burden for home caregivers and can affect their quality of life. The implementation of formal home help (personalized autonomy allowance for seniors) can relieve home caregivers and improve their quality of life.

Conduct of research:

Elderly patients followed in the geriatric department of the Mulhouse French hospital, and for whom a formal home help (personalized autonomy allowance for seniors) is initiated will be recruited. The evolution of home caregiver's quality of life, burden and vulnerability, will be assessed during three months.

Eligibility criteria: Inclusion criteria:

* Patient 60 years of age or older
* Diagnosis of neurocognitive disorders
* MMSE score less than or equal to 26
* GIR score inferior or equal to 4
* Introduction of formal home help (personalized autonomy allowance for seniors program)
* Patient living in Haut-Rhin department (France)
* Patient receiving regular informal help at home (at least once a week)
* Availability of the current home helper to participate in the sudy
* Non-opposition to participation in the study

Exclusion criteria:

* Introduction of formal home care not related to the personalized autonomy allowance program
* Patient under legal protection

Primary outcomes:
measure: Caregiver quality of life
timeFrame: 90 days
Secondary outcomes:
measure: Caregiver vulnerability
timeFrame: 90 days
measure: Caregiver burden
timeFrame: 90 days
measure: Caregiver quality of life according to the type of formal home care
timeFrame: 90 days
measure: Caregiver vulnerability according to the type of formal home care
timeFrame: 90 days
measure: Caregiver burden according to the type of formal home care
timeFrame: 90 days
measure: Variation of quality of life score according to each domain
timeFrame: 90 days
measure: Description of the aids set up within the framework of the personalized autonomy allowance for seniors program.
timeFrame: 90 days
Other outcomes:
Locations:
city: Mulhouse
country: France
facility: GHRMSA
state: Haut-Rhin
Study officials:
References: